Checking import rules for research products, country by country

No single rule covers research peptides across the GCC. Each country has its own medicines authority, customs agency and import process, and none of them is bound by a supplier’s “ships to the GCC” banner. This guide does not tell you what is legal. We cannot, and anyone who claims to answer that for all six countries at once should be treated with caution. What it does is point you to the right official body in each country and give you the questions that get a useful answer.

Three separate questions

1. Is the product a registered medicine here? Registration is country-specific and product-specific.
2. If not, may it be imported for laboratory research, and by whom? Rules can differ for individuals, companies and licensed institutions.
3. How must the parcel be declared, and who pays duties and taxes? The cross-border policies we captured (SHLabz and Dubai Peptides) put this on the recipient.

Who to ask, country by country

Each country hub’s regulations page links the official sites and records the date we checked them.

Before you contact an authority

• Have the exact compound name, and any alternative names. The library lists common aliases.
• Have the supplier’s certificate of analysis and the product’s format (sealed powder, pre-filled pen, spray).
• Be clear about who would import: you personally, a company or a laboratory.
• Ask what documents customs will expect to see with the parcel.

What supplier terms tell you about the risk

The cross-border policies we captured from SHLabz and Dubai Peptides agree on one point: the recipient carries the customs risk. One supplier’s policy says a parcel refused, returned or rejected because of local import requirements is not refundable. Another says it can only assess a refund once a parcel returned by customs is back at its Dubai facility. Read these clauses before ordering cross-border. They tell you that the seller does not guarantee clearance.

Rules change

Regulators reorganise. The UAE’s federal medical-products regulator, for example, is a recent body. Treat any regulatory summary, including ours, as a pointer to check, not a ruling, and look at the “reviewed” date on each country page.